Home-based Intervention With Semaglutide Treatment Of Neuroleptica-Related Prediabetes
A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 154 participants.
Also called NCT05193578
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 2
- Enrolled
- 154 participants
- Registry
-
NCT05193578
-
- Other papers using this trial's data
- Semaglutide Treatment of Antipsychotic-Treated Patients With Schizophrenia, Prediabetes, and Obesity: The HISTORI Randomized Clinical Trial
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- Denmark
- Registry status
- Completed
Technical summary
Registry record NCT05193578. Randomized; quadruple masking; primary purpose treatment. Start 2022-01-01 (actual); primary completion 2024-03-18 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Home-based Intervention With Semaglutide Treatment Of Neuroleptica-Related Prediabetes
- Acronym
- HISTORI
- Condition
- Schizophrenia
- Condition
- Prediabetic State
- Intervention (Drug)
- Semaglutide, 1.34 mg/mL
- Intervention (Other)
- Placebo
- Lead sponsor
- Jan Frystyk
- Collaborator
- Region Zealand
- Collaborator
- Region of Southern Denmark
- Collaborator
- Steno Diabetes Center Sjaelland
- Collaborator
- Steno Diabetes Center Odense
Record details
- Record id
cardio:ct-nct05193578- Content hash
05b29c5c36cb0c09a4805ddefea06758d10cd470ce95cdedd0991ea478a61c44